Trials / Completed
CompletedNCT05486247
Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel
Molecular Characterization of Gliomas Using a Broad NGS Panel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Hellenic Cooperative Oncology Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Gliomas are the most common malignant primary brain tumors with poor prognosis. The genotyping of tumors using NGS platforms enables the identification of genetic alterations that constitute diagnostic, prognostic and predictive biomarkers.Here in, we investigated the molecular profile of 32 tumor samples from 32 patients with high grade gliomas by implementing a broad 80-gene targeted NGS panel while reporting their clinicopathological characteristics and outcomes.
Conditions
Timeline
- Start date
- 2015-02-04
- Primary completion
- 2021-12-01
- Completion
- 2022-05-01
- First posted
- 2022-08-03
- Last updated
- 2022-08-03
Source: ClinicalTrials.gov record NCT05486247. Inclusion in this directory is not an endorsement.